Novartis Italia promotes active patient participation in breast cancer care

Chiara Gnocchi, Communications & Patient Advocacy Head at Novartis Italia, has highlighted the need to transition patient trust into active participation regarding breast cancer treatment. Commenting on Iqvia research regarding early-stage Hr+/Her2- breast cancer during Breast Cancer Awareness Month, Gnocchi noted that while three out of four women feel heard by their doctors, there is a significant gap in awareness regarding the risk of recurrence.

To address this, Novartis Italia has launched the ‘Facciamo Squadra’ campaign in collaboration with patient associations including Europa Donna, Andos, Salute Donna, and Incontro Donna. The initiative aims to foster a more conscious dialogue between clinicians and patients to help women make informed decisions about their treatment paths and holistic management of the disease.